Knockout Mouse Catalog | Cyagen APAC
Cyagen Closes $41 Million Series B to Expand Animal Research Model Business
Cyagen Biosciences Suzhou Inc. closed a 285 million RMB (equivalent to about $41 million USD) Series B financing as of Feb 25. The investments are from funds managed by CMS Capital, GF Qianhe and GF Xinde which are both wholly owned by GF securities, and Guanghua Investment respectively. Read More ›
Cyagen Biosciences and Taconic Biosciences Announce Strategic Partnership
Rensselaer, NY — July 18, 2018 - Cyagen Biosciences and Taconic Biosciences, global leaders in the generation of custom genetically engineered rodent models and associated services, announced a strategic partnership. Read More ›